Scoliosis in patients with prader-willi syndrome

Pediatrics

Volumn 122, Issue 2, 2008, Pages

  Odent, Thierry ^a,f   Accadbled, Franck ^a   Koureas, Georges ^a   Cournot, Maxime ^b   Moine, Alexandre ^a   Diene, Gwenaelle ^c   Molinas, Catherine ^c   Pinto, Graziella ^d   Tauber, Maïthe ^c   Gomes, Bruno ^e   De Gauzy, Jérôme Sales ^a   Glorion, Christophe ^a  

^a Department of Orthopaedic Surgery ^*  (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c Hôpital des Enfants   (France)

^d HÔPITAL DES ENFANTS   (France)

^e Royal Newcastle Centre   (Australia)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Growth and nutrition; Growth hormone treatment; Prader willi syndrome; Scoliosis

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; DISEASE ASSOCIATION; FEMALE; HUMAN; KYPHOSIS; MAJOR CLINICAL STUDY; MALE; PRADER WILLI SYNDROME; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCOLIOSIS; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; COMORBIDITY; DISEASE COURSE; FOLLOW UP; HOSPITALIZATION; LONGITUDINAL STUDY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; PRESCHOOL CHILD; PROBABILITY; RADIOGRAPHY; REFERENCE VALUE; SEX RATIO; STATISTICAL MODEL;

ADOLESCENT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GROWTH HORMONE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MULTIVARIATE ANALYSIS; PRADER-WILLI SYNDROME; PREVALENCE; PROBABILITY; REFERENCE VALUES; RETROSPECTIVE STUDIES; SCOLIOSIS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION;

EID: 49849098335     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2007-3487     Document Type: Article

References (16)

1. Prader A, Labhart A, Willi H. A syndrome with adiposity, stunted growth, cryptocordia and oligophrenia after myotonia entitled in newborn. [in German]. Schweiz Med Wochenschr. 1956;86:1260-1261
2. Holm VA, Cassidy SB, Butler MG, et al. Prader-Willi syndrome:consensus diagnostic criteria. Pediatrics. 1993;91(2):398-402
3. Gunay-Aygun M, Schwartz S, Heeger S, O'Riordan MA, Cassidy SB. The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria. Pediatrics. 2001;108(5). Available at: www.pediatrics.org/cgi/content/full/108/5/e92
4. Bachere N, Diene G, Delagnes V, Molinas C, Moulin P, Tauber M. Early diagnosis and multidisciplinary care reduce the hos-pitalization time and duration of tube feeding and prevent early obesity in PWS infants. Horm Res. 2008;69(1):45-52
5. Myers SE, Carrel AL, Whitman BY, Allen DB. Sustained benefit after 2 years of GH on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome. J Pediatr. 2000;137(1):42-49
6. Whitman B, Carrel A, Bekx T, Weber C, Allen D, Myers S. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after sixmonths. J Pediatr Endocrinol Metab. 2004;17(4):591-600
7. Cassidy SB, Forsythe M, Heeger S, et al. Comparison of phe-notype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet. 1997;68(4):433-440
8. Mascari M, Gottlieb W, Rogan P, et al. The frequency of uni-+parental disomy in Prader-Willi syndrome: implications for molecular diagnosis. N Engl J Med. 1992;326(24):1599-1607 9. Gurd AR, Thompson TR. Scoliosis in Prader-Willi Syndrome. J Pediatr Orthop. 1981;1(3):317-320
9. Kroonen LT, Herman M, Pizzutillo PD, Macewen GD. Prader-Willi syndrome: clinical concern for the orthopaedic surgeon. J Pediatr Orthop. 2006;26(5):673-679
10. Nagai T, Obata K, Ogata T, et al. Growth hormone therapy and scoliosis in patients with Prader-Willi syndrome. Am J Med Genet A. 2006;140(15):1623-1627
11. Day G, McPhee I, Batch J, Tomlinson F. Growth rates and the prevalence and progression of scoliosis in short-statured children on Australian growth hormone treatment programmes. Scoliosis. 2007;2:3
12. Tokutomi T, Chida A, Asano Y, et al. A non-obese boy with Prader-Willi syndrome shows cardiopulmonary impairment due to severe kyphoscoliosis. Am J Med Genet A. 2006;140: 1978-1980
13. Rees D, Jones MW, Owen R, Dorgan JC. Scoliosis surgery in the Prader-Willi syndrome. J Bone Joint Surg Br. 1989;71: 685-688
14. Accadbled F, Odent T, Moine A, et al. Complications of scoliosis surgery in Prader-Willi syndrome. Spine. 2008;33(4):394-401
15. Tauber M. Effects of growth hormone treatment in children presenting with Prader-Willi syndrome: the KIGS experience. In: Ranke MB, Price DA, Reiter EO, eds. Growth Hormone Therapy in Pediatrics: 20 Years of KIGS. Basel, Switzerland: Karger; 377-387
16. Docquier PL, Mousny M, Jouret M, Bastin C, Rombouts JJ. Orthopaedic concerns in children with growth hormone therapy. Acta Orthop Belg. 2004;70(4):299-305